|Published||Report Code||Available Format||Pages|
Molecular biology kits & reagents, and enzymes are the products used to perform cloning, RNA analysis, DNA sequencing, protein analysis, DNA isolation, RNA extraction and polymerase chain reaction (PCR). These products are commonly used to perform various diagnostic tests, molecular tests, genetic analysis and help in drug discovery and development. Molecular biology products are associated with the fields of cell biology, biochemistry and genetics, allowing scientists to understand the cellular systems better with more simplification. Molecular biology kits and reagents are being used within the protocol for diagnosing patients suffering from infections, cancer and diabetes. The factors such as increase in incidence of infectious diseases and prevalence of cancer, increase in the geriatric population, rise in genetic disorders and expansion in healthcare expenditure drive the growth of this market.
GLOBAL MOLECULAR BIOLOGY KITS & REAGENTS AND ENZYMES MARKET, BY END USER, $M (2012 – 2022)
With the help of molecular biology kits and reagents, and enzymes, DNA extraction process takes place from the cells or viruses. It is the initial step in diagnosing diseases and genetic disorders such as sickle cell anemia, Alzheimer’s disease and cystic fibrosis. The techniques used to extract DNA includes fluorescence in situ hybridization (FISH), terminal restriction fragment length polymorphism (T-RFLP) and sequencing.
Based on product, the global molecular biology kits and reagents, and enzymes market is segmented into kits and reagents, and enzymes. Kits and reagents held the larger share in the global molecular biology kits and reagents, and enzymes market in 2015. Among different applications, the global market for sequencing is expected to witness the highest growth during the forecast period. The highest demand for molecular biology kits and reagents, and enzymes was in polymerase chain reaction (PCR).
Academic and research institutes, hospital and diagnostic centers, and pharmaceutical and biotechnology companies are the key end user of molecular biology kits and reagents, and enzymes. The largest demand for molecular biology kits and reagents, and enzymes was in academic and research institutes.
The global molecular biology kits and reagents and enzymes market was valued at $4,928.3 million in 2015 and it is expected to grow at a CAGR of 17.2% during 2016 - 2022. Increasing cases of genetic disorders, increasing healthcare expenditure, growing aging population, and increasing prevalence of cancer and incidence of infectious diseases are the major factors driving the growth of the global molecular biology kits and reagents, and enzymes market. Some of the challenges hindering the growth of the market include high cost and mishandling of genetic information.
The increase in number of collaborations and agreements, and rising number of product launches are the major trends witnessed in the global molecular biology kits & reagents and enzymes market. In the past few years, the molecular biology kits & reagents and enzymes market has witnessed a rise in number of collaborations and agreements based on various strategic business reasons. In October 2016, New England Biolabs, Inc. entered into an agreement with AmpTec GmbH to supply critical reagents to AmpTec GmbH for manufacturing synthetic long RNAs and functional mRNAs for research, diagnostic and therapeutic applications. With this agreement, New England Biolabs, Inc. strengthened its position as a key supplier to the fast-growing RNA synthesis market. Similarly, in April 2016, Agilent Technologies Inc. entered into an agreement with Applied Spectral Imaging (ASI) to jointly market ASI's most advanced GenASIs imaging platforms and Agilent's fluorescence in situ hybridization (FISH) products and solutions, including Dako Omnis instrument for automated FISH sample processing. The agreement provided pathology labs with fully automated, end-to-end FISH workflow.
The demand for molecular biology kits and reagents, and enzymes is increasing due to significant growth in the number of people suffering from infectious diseases and cancer. The incidence of infectious diseases, such as HIV, HPV, HCV and healthcare associated infections (HCAIs) is increasing, due to lack of access to preventive care and poor lifestyle. According to the Joint United Nations Programme on HIV/AIDS (UNAIDS) globally, approximately 36.7 million people suffered from HIV infection, in 2015. In addition, according to the WHO, 8.2 million deaths took place globally due to cancer in 2012, out of which 1.6 million deaths were due to lung cancer, while 745,000 deaths were due to liver cancer, and 400,000 deaths were a result of esophageal cancer.
The global market is highly consolidated with two companies including Thermofisher Scientific Inc. and Merck KGaA accounting for more than 45% share. Thermofisher Scientific Inc. held the largest share of the global molecular biology kits and reagents, and enzymes market in 2015. Thermofisher Scientific Inc. is highly active in the global market. In March 2016, the company acquired, Affymetrix, Inc, provider of cellular and genetic analysis products at a price of approximately $1.3 billion, This strengthening the company’s position in biosciences and genetic analysis. This acquisition also expands product portfolio and geographical reach of antibodies, kits & reagents, enzymes and assays for high-growth molecular biology applications. Other key players in the market include Promega Corporation, F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, New England Biolabs, Inc., Qiagen N.V., Illumina, Inc., Takara Bio Inc. and Agilent Technologies.
P&S Intelligence offers customization as per specific business requirements of clients. Illustrative customization within the scope of this report includes: